These findings supplement our understanding of ACE inhibition by the clinically used ACE inhibitors, and this information should be useful in the future design of more domain‐selective inhibitors for the treatment of hypertension and cardiovascular diseases. This evidence concerns the gene ACE and hypertensive disorder.